Patients who undergo organ transplantation receive immunosuppressive drugs in the posttrans-plant period. All of these drugs influence host metabolic response or alter nutrient intake. One of the most prominent aspects of the posttransplant period is the occurrence of hyperlipidemia, which may require dietary or pharmacologic control. Dietary recommendations for this patient population include limiting carbohydrate intake, restricting caloric intake to maintain ideal body weight, and maintaining a low cholesterol/saturated fat diet.
Get full access to this article
View all access options for this article.
References
1.
Cecka J., Terasaki P.The UNOS scientific transplant registry-1991. Clin Transplant1991;1-11.
2.
Belle S., Beringer K., Murphy J., et al. Liver transplantation in the United States: 1988 to 1990. Clin Transplant1991;13-29.
3.
Sutherland D. , Gruessner A., Moudry-Munns K.Report on results of pancreas transplantation in the United States October 1987 to October 1991 from the United Network for Organ Sharing Registry. Clin Transplant1991;31-8.
4.
Kaye M.Registry report: International Society for Heart and Lung Transplantation . Clin Transplant1991;39-44.
5.
United Network for Organ Sharing Update1992 ;8:39.
6.
Ghosh P., Evans D., Tomlinson A., et al. Plasma lipids following renal transplantation. Transplantation1973;15:521-3.
7.
Casaretto A. , Marchioro T., Goldsmith R.Hyperlipidemia after successful renal transplantation . Lancet1974;1:481-4.
8.
Markell M., Friedman A.Hyperlipidemia after organ transplantation. Am J Med1989;87(5N):61N-7N.
9.
Saldanha L., Hurst K., Amend W., et al. Hyperlipidemia after renal transplantation in children. Am J Dis Child1976;130:953.
10.
Gokal R., Mann J., Moore R., et al. Hyperlipidemia following renal transplantation. Q J Med1979;64:634.
11.
Reisman L., Lieberman K., Burrows L., et al. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation1990;49:76-80.
12.
Harris K., Russell G., Parvin S., et al. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J1986;292:16.
13.
Vathsala A. , Weinberg R., Schoenberg L., et al. Lipid abnormalities in cyclosporine-prednisone treated renal transplant recipients. Transplantation1989;48:37-40.
14.
Kasiske B., Uman A.Persistent hyperlipidemia in renal transplant patients. Medicine1987;66:309-16.
15.
Chan M., Varghese Z., Persaua J., et al. The role of multiple pharmacotherapy in the pathogenesis of hyperlipidemia after renal transplantation. Clin Nephrol1981;15:309-13.
16.
Vega G., Grundy S.Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism . Kidney Int1988;33:1160-8.
17.
Bagdade J., Albers J.Plasma high-density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med1977 ;296:1436-9.
18.
Ibels L., Alfrey A., Weil R.Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients . Am J Med1978;64:642.
19.
Ponticelli C. , Barbi G., Cantaluppi A., et al. Lipid disorders in renal transplant recipients. Nephron1978 ;20:189-95.
20.
Kasiske BL, Umen AJPersistent hyperlipidemia in renal transplant patients. Medicine1987;66:309-16.
21.
Shen S., Lukens C., Alongi S., et al. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia. Kidney Int [Suppl]1983 ;16:5147-52.
22.
Nelson J., Beauregard H., Gelinas M., et al. Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet. Transplant Proc1988;20:1264-70.
23.
Larsen J., Stratta R., Ozaki C., et al. Lipid status after pancreas-kidney transplantation. Diabetes Care1992;15:35-42.
Moore R., Callahan M., Cody M., et al. The effect of the American Heart Association Step One Diet on hyperlipidemia following renal transplantation. Transplantation1990;49:60-2.
26.
Kasiske B., Tortorice K., Heim-Duthoy K., et al. Lovastatin treatment of hypercholesterolemia in renal transplant recipients. Transplantation1990;49:95-100.
27.
Kuo P., Kirshenbaum J., Gorden J., et al. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol1989;64:631-5.
28.
Norman D., Illingworth D., Munson J., et al. Myolysis and acute renal failure in a heart transplant recipient receiving lovastatin. N Engl J Med1988;318:46-7.
29.
East C., Alivizatos P., Grundy S., et al. Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med1988;318:47-8.
30.
Kinlen L.: Fat and cancer aetiology. Prog Lipid Res, 1986;25: 527-31.
31.
Miller J., Zilkha K., Langman M., et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J1973;1:765-8.
32.
Alexander J. , Smito H., Trocki O., et al. The importance of lipid type in the diet after burn injury. Ann Surg1986;204:1-8.
33.
Gurr M.The role oflipids in the regulation ofthe immune system. Prog Lipid Res1983;22:257-87.
34.
Foegh M., Alijani M., Helfrich G., et al. Fatty acids and eicosanoids in organ transplantation. Prog Lipid Res1986;25:567-72.
35.
Mertin J.Effect of polyunsaturated fatty acids on skin allograft survival and primary and secondary cytotoxic response in mice. Transplantation1976;21:1-4.
36.
Kort WS, Weijman I., Westbrock D.Effect of stress and dietary fatty acids on allograft survival in the rat . Eur Surg Res1979;11:434-44.
37.
Ring J., Seifert J., Mertin J., et al. Prolongation of skin allografts in rats by treatment with linoleic acid. Lancet1974;2:1331-2.
38.
Perez R., Munda R., Alexander J.Dietary immunoregulation of transfusion-induced immunosuppression . Transplantation1988;45:614.
39.
Perez R., Munda R., Alexander J.Augmentation of donor-specific transfusion and cyclosporine effects with dietary linoleic acid. Transplantation1989;47:937-40.
40.
Uldall P., Wilkinson R., McHigh M., et al. Unsaturated fatty acids and renal transplantation [Letter]. Lancet1974;2:514.
41.
Homan van der Heide J., Bilo H., Donker A., et al. The effects of dietary supplementation with fish oil on renal function and in the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients. Transplantation1992; 54:257-63.
42.
Homan van der Heide J., Bilo H., Tegzess A., et al. The effects of dietary supplementation with fish oil on renal function in cyclosporin-treated renal transplant recipients . Transplantation1990;49:523-7.
43.
Pagenkemper J., Foulks C.Nutritional management of the adult renal transplant patient. J Renal Nutr1991 ;1:119-24.
44.
Edwards M., Doster S.Renal transplant diet recommendations: results of a survey of renal dietitians in the United States. J Am Diet Assoc1990 ;90:843-6.
